Episode 277: 276. REDUCE-MI Trial- Should we still Give BBlockers Post-MI?
A study that was done before the widespread use of troponin only measurements for ACS (and certainly before high sensitively trop EVER EXISTED), a trial that took place before the first statin was even FDA approved, a trial that had no idea what DAPT was and took place PRIOR to the publication of the trial that would ultimately make aspirin post MI a standard of care, a trial that existed before a standard 90 minute door to balloon time.
As a reminder this trial (ISIS) didn’t demonstrate a huge mortality benefit despite all of the things that were missing from it that are now considered standard of care. The mortality number needed to treat was 143 (13.3% vs 14.0%)
https://www.nejm.org/doi/abs/10.1056/NEJMoa2401479
Create your
podcast in
minutes
It is Free